Improving Evidence-Based Care for Cancer Patients

N/ACompletedNCT03207594

Medical University of South Carolina128 enrolled

Overview

The purpose of this study is to improve cancer care and the delivery of cancer care. Researchers are interested in studying patient reported information and examining how different factors may impact cancer care.

Study Type

OBSERVATIONAL

Enrollment

128

Conditions

Head and Neck Cancer Prostate Cancer Breast Cancer Lung Cancer Gynecologic Cancer Gastrointestinal Cancer

Interventions

SurveyOTHER

Subjects will be asked to complete a survey asking questions about his/her current health, well-being and quality of life.

Saliva sampleOTHER

Subjects will have saliva collected by a member of the study team using a cotton swab.

Smoking Status questionsOTHER

Subjects will be asked to complete an assessment asking questions about his/her current smoking status

Eligibility

Sex: ALLMin age: 21 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosed with head/neck, lung, breast, prostate, gastrointestinal or gynecologic cancer * 21 years of age or older at time of study registration * Must have been referred to MUSC radiation oncology for treatment with curative radiation therapy * Must report current smoking defined as self-reporting smoking within the past 30 days using a structured intake questionnaire. Exclusion Criteria: * Patients with primary central nervous system malignancies will be excluded. * Patients that have other cancer disease types will be excluded due to either significant differences in standard radiation therapy approaches or rarity of disease required radiation. * Patients who are currently participating in the Medical University of South Carolina Hollings Cancer Center smoking cessation program * Patients who are unable to provide informed consent

Locations (1)

Medical University of South Carolina

Charleston, South Carolina, United States

Outcomes

Primary Outcomes

Number of patients with biochemically confirmed smoking cessation

Biochemical confirmation will be determined by saliva samples

Time frame: 4 weeks after enrollment

Number of patient who self-report smoking cessation

Self-reported smoking cessation will be documented via smoking assessment questionnaire

Time frame: 4 weeks after enrollment

Secondary Outcomes

Average weekly smoke exposure

reported cigarettes per day multiplied by the number of days smoked during radiation therapy (RT), summed over a period of time and normalized to yield an average weekly smoke exposure during RT.

Time frame: up to 62 weeks

Number of patients who participate in smoking cessation

Completing one in-person visit where an individualized smoking cessation treatment plan is developed and implemented.

Time frame: up to 12 months after completion of RT.

Compliance with smoking cessation

Two binary measure of compliance: 1. \- completing at least three in person visits within 6 weeks of starting an individualized cessation treatment plan 2. \- completing at least one in-person visit and at least two phone-based communications

Time frame: up to 12 weeks after completion of RT

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.